An Intellectual Salon for Scientific Leaders
Relapse prevention remains the single greatest unmet need in schizophrenia treatment. Despite advances in pharmacotherapy, the cycle of relapse continues to disrupt lives and derail recovery.
Join NWPharmaTech for an intimate, off-the-record dinner discussion during the SIRS 2026 Annual Congress. We convene a curated group of 25 senior stakeholders—clinicians, trialists, regulators, and investors—to explore the scientific thesis for a new category of non-dopaminergic, oral maintenance therapy.
This is not a corporate presentation. It is a dialogue about the future of the field.
Leading the Conversation
Professor John Kane
Scientific Lead & Keynote
Professor Kane will anchor the evening with a thought-provoking perspective on the limitations of current acute treatments and the biological rationale for a new approach to maintenance.
Key Discussion Themes:
- Limitations of LAIs and oral dopaminergic agents
- Time-to-relapse as a validated regulatory endpoint
- The case for non-dopaminergic maintenance mechanisms
- Clinical trial design for the next era of development
Sabatini Firenze
A historic landmark protected by the Fine Arts authority. We have secured the private "Delia" Room, offering an intimate, exclusive setting for open dialogue.
Via Panzani 9A, Florence
5-minute walk from Firenze Fiera (SIRS Congress Venue)
Evening Agenda
Thursday, March 26, 2026
Arrival & Aperitivo
Welcome drinks and networking
Seated Dinner Begins
Guests guided to the Delia Room
Fireside Perspective
Professor John Kane on the future of relapse prevention
Open Discussion
Moderated Q&A and peer dialogue
Close
Coffee and closing remarks
Request Your Seat
Attendance is strictly limited to 25 guests to ensure a high-quality discussion.